1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19
on Global Carrier Screening Market
5. Voice of Customer
6.
Global Carrier Screening Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Type (Expanded Carrier Screening v/s Targeted Cancer
Screening)
6.2.2. By Screening Type (Prenatal Carrier Testing v/s
Preconception Carrier Screening)
6.2.3. By Technology (Next Generation Sequencing, Polymerase
Chain Reaction, Microarrays, Others)
6.2.4. By Indication (Cystic Fibrosis, Down’s Syndrome,
Thalassemia, Tay-Sachs Disease, Huntington’s Disease, Sickle Cell Anemia,
Others)
6.2.5. By End User (Hospitals & Clinics, Reference
Laboratories, Others)
6.2.6. By Region
6.2.7. By Company (2021)
6.3. Market Map
7.
North America Carrier Screening Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Screening Type
7.2.3. By Technology
7.2.4. By Indication
7.2.5. By End User
7.2.6. By Country
7.3. North America:
Country Analysis
7.3.1. United States Carrier
Screening Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Screening Type
7.3.1.2.3.
By Technology
7.3.1.2.4.
By Indication
7.3.1.2.5.
By End User
7.3.2. Canada Carrier
Screening Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Screening Type
7.3.2.2.3.
By Technology
7.3.2.2.4.
By Indication
7.3.2.2.5.
By End User
7.3.3. Mexico Carrier
Screening Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Screening Type
7.3.3.2.3.
By Technology
7.3.3.2.4.
By Indication
7.3.3.2.5.
By End User
8.
Europe Carrier Screening Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Type
8.2.2. By Screening Type
8.2.3. By Technology
8.2.4. By Indication
8.2.5. By End User
8.2.6. By Country
8.3. Europe: Country
Analysis
8.3.1. France Carrier
Screening Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Screening Type
8.3.1.2.3.
By Technology
8.3.1.2.4.
By Indication
8.3.1.2.5.
By End User
8.3.2. Germany Carrier
Screening Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Screening Type
8.3.2.2.3.
By Technology
8.3.2.2.4.
By Indication
8.3.2.2.5.
By End User
8.3.3. United Kingdom Carrier
Screening Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Screening Type
8.3.3.2.3.
By Technology
8.3.3.2.4.
By Indication
8.3.3.2.5.
By End User
8.3.4. Italy Carrier
Screening Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Screening Type
8.3.4.2.3.
By Technology
8.3.4.2.4.
By Indication
8.3.4.2.5.
By End User
8.3.5. Spain Carrier
Screening Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Screening Type
8.3.5.2.3.
By Technology
8.3.5.2.4.
By Indication
8.3.5.2.5.
By End User
9.
Asia-Pacific Carrier Screening Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Screening Type
9.2.3. By Technology
9.2.4. By Indication
9.2.5. By End User
9.2.6. By Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China Carrier
Screening Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Screening Type
9.3.1.2.3.
By Technology
9.3.1.2.4.
By Indication
9.3.1.2.5.
By End User
9.3.2. India Carrier
Screening Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Screening Type
9.3.2.2.3.
By Technology
9.3.2.2.4.
By Indication
9.3.2.2.5.
By End User
9.3.3. Japan Carrier
Screening Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Screening Type
9.3.3.2.3.
By Technology
9.3.3.2.4.
By Indication
9.3.3.2.5.
By End User
9.3.4. South Korea Carrier
Screening Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Type
9.3.4.2.2.
By Screening Type
9.3.4.2.3.
By Technology
9.3.4.2.4.
By Indication
9.3.4.2.5.
By End User
9.3.5. Australia Carrier
Screening Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Type
9.3.5.2.2.
By Screening Type
9.3.5.2.3.
By Technology
9.3.5.2.4.
By Indication
9.3.5.2.5.
By End User
10.
South America Carrier Screening Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Type
10.2.2. By Screening Type
10.2.3. By Technology
10.2.4. By Indication
10.2.5. By End User
10.2.6. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Carrier
Screening Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Screening Type
10.3.1.2.3.
By Technology
10.3.1.2.4.
By Indication
10.3.1.2.5.
By End User
10.3.2. Argentina Carrier
Screening Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Screening Type
10.3.2.2.3.
By Technology
10.3.2.2.4.
By Indication
10.3.2.2.5.
By End User
10.3.3. Colombia Carrier
Screening Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Screening Type
10.3.3.2.3.
By Technology
10.3.3.2.4.
By Indication
10.3.3.2.5.
By End User
11.
Middle East and Africa Carrier Screening Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Type
11.2.2. By Screening Type
11.2.3. By Technology
11.2.4. By Indication
11.2.5. By End User
11.2.6. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Carrier
Screening Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Type
11.3.1.2.2.
By Screening Type
11.3.1.2.3.
By Technology
11.3.1.2.4.
By Indication
11.3.1.2.5.
By End User
11.3.2. Saudi Arabia Carrier
Screening Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Type
11.3.2.2.2.
By Screening Type
11.3.2.2.3.
By Technology
11.3.2.2.4.
By Indication
11.3.2.2.5.
By End User
11.3.3. UAE Carrier
Screening Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Type
11.3.3.2.2.
By Screening Type
11.3.3.2.3.
By Technology
11.3.3.2.4.
By Indication
11.3.3.2.5.
By End User
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape (Inclusive of SWOT Analysis)
Eurofins
Scientific, Inc.
Fulgent Genetics, Inc.
CENTOGENE N.V.
Invitae Corporation
Illumina, Inc.
Gene by Gene, Ltd.
Laboratory Corporation of America Holdings
Natera, Inc.
Myriad Genetics, Inc.
Quest Diagnostics, Inc.
15. Strategic Recommendations